1. Home
  2. DSX vs AKBA Comparison

DSX vs AKBA Comparison

Compare DSX & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.22

Market Cap

291.1M

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.30

Market Cap

251.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
AKBA
Founded
1999
2007
Country
Greece
United States
Employees
939
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.1M
251.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DSX
AKBA
Price
$2.22
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.67
AVG Volume (30 Days)
616.8K
5.5M
Earning Date
05-28-2026
05-07-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
93.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.28
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.82
52 Week High
$2.92
$4.02

Technical Indicators

Market Signals
Indicator
DSX
AKBA
Relative Strength Index (RSI) 53.22 55.49
Support Level $2.17 $1.16
Resistance Level $2.24 $1.54
Average True Range (ATR) 0.07 0.08
MACD 0.02 -0.01
Stochastic Oscillator 90.00 48.68

Price Performance

Historical Comparison
DSX
AKBA

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: